» Download Public Reports
21 reports
- Country report
- October 2012
- 22 pages
... Antimonopoly service, etc ) Resolve bottlenecks in technology transfer i.E. Through tech transfer offices, professional training, capacity building Improve clinical trial environment Strengthen ip ...
March 2011
... Development (c&d) specialist that conducts clinical trials for new drugs developed by other drug makers and then makes licensing out deals for these products. Holding licenses to sell Zydena (Developed ...
March 2011
... Includes further development costs of at001/r84 to support the clinical trials. Development costs in the first quarter were higher due to more external activities on at001/r84. Administrative expenses ...
September 2011
... Tech and nanotechnology, to provide funding for cbli's new subsidiary, panacela labs, inc., Which will develop a portfolio of new preclinical drug cands. According to the terms of the agreement, rusnano will invest up ...
February 2012
... Diabetes as well as an inhaled version for the treatment of a central nervous system (cns) indication. Sulixen has completed phase i human clinical trials in russia for the diabetes indications ...
December 2011
... And uncertainties facing the group may be summarised as follows: a) that the scientific programmes may not successfully complete clinical trials and regulatory approval processes; b) potential loss of key ...
February 2013
... Are the same Using of the cros with strong regional presence can decrease the costs Logistics issues (shipment of clinical trial materials to the distant sites: shipment of biosamples to the central lab ...
June 2012
... By the investigator in case of events that may be considered as an insured accident during a clinical trial. Approximate price of clinical study examination by sec is 4000 euro additional requests by lec and sec ...